Total Funding
32
1
Total FundingVenture - Series Unknown raised
Growth Score
-6 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1011035
AIT Bioscience offers bioanalytical contract research services for preclinical and clinical trials.
Acquired by 
Nexelis
Ron Shoup: President- Terry Spartz: COO
About the Company
AIT Bioscience offers bioanalytical contract research services for pre-clinical and phases I to III clinical trials. The company provides drug discovery analyses, protein analysis, and uses ligand-binding assays to provide immunogenicity information to support clinical and non-clinical studies. It employs electronic systems that detect and resolve
potential deviations and errors in real-time.
AIT Bioscience, operating as a subsidiary of the American Institute of Toxicology, was founded in 2009 and is based in Indianapolis, Indiana.
